International Biotechnology (LON:IBT) Shares Cross Above 200 Day Moving Average – Here’s What Happened

Shares of International Biotechnology (LON:IBT) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 971.47 and traded as high as GBX 1,096.39. International Biotechnology shares last traded at GBX 1,085, with a volume of 102,357 shares traded.

International Biotechnology Price Performance

The stock has a 50 day moving average of GBX 1,035.10 and a 200-day moving average of GBX 971.47. The company has a debt-to-equity ratio of 9.43, a quick ratio of 0.32 and a current ratio of 0.11. The company has a market cap of £345.33 million, a PE ratio of 4.49 and a beta of 0.52.

International Biotechnology (LON:IBT) last released its quarterly earnings data on Tuesday, May 12th. The company reported GBX (4.83) earnings per share for the quarter. The business had revenue of GBX 24 million during the quarter. International Biotechnology had a return on equity of 27.35% and a net margin of 82.27%. Equities analysts predict that International Biotechnology will post 0.9435943 earnings per share for the current year.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.